Global Computer Aided Diagnosis (CAD) Market

Computer Aided Diagnosis (CAD) Comprehensive Study by Type (Breast CAD, Abdominal CAD, Prostate CAD, Chest CAD, Others), Application (Cancer {Breast Cancer, Lung Cancer, Colon Cancer, Prostate Cancer, Liver Cancer, Bone Cancer, & Others}, Neurological, Musculoskeletal, Cardiovascular, Others), Imaging Modality (X-Ray Imaging, Computed Tomography, Ultrasound Imaging, Magnetic Resonance Imaging, Nuclear Medicine Imaging, Others), End-User (Hospitals, Diagnostic Centers, Research Centers, Others) Players and Region - Global Market Outlook to 2030

Computer Aided Diagnosis (CAD) Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Computer Aided Diagnosis (CAD)
Computer-Aided Diagnosis (CAD) Forms an Important Part of the Routine Clinical Work for Detection of Diseases at Many Hospital & Screening Sites. It Helps the Radiologist to Make Final Decision About Diagnosis. It Finds Its Usage in the Detection & Differential Diagnosis of Many Different Types of Abnormalities in Medical Images Obtained in Various Examinations by Use of Different Imaging Modalities.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


The Market for the Computer-Aided Diagnosis is Fragmented with the Presence of Many Players. Leading Players Can Adopt Strategies Like a Merger, Acquisition, Expansion, New Product Launch, in Order to Gain Share Within the Market. Owing to the Booming Healthcare Industry, there are Growing Prospects for the New Players to Enter the Market Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Computer Aided Diagnosis (CAD) market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Siemens Healthineers (Germany), IBM (United States), Hitachi High Technologies Corporation (Japan), GE Healthcare (United States), EDDA Technology, Inc. (United States), Fujifilm Holdings Corporation (Japan), Hologic Inc. (United States), iCAD, Inc. (United Kingdom) and Philips (Netherlands) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Median Technologies (France), Carestream Health (United States), ESAOTE SpA (Italy), Riverain Technologies (United States) and Others.

Segmentation Overview
AMA Research has segmented the market of Global Computer Aided Diagnosis (CAD) market by Type (Breast CAD, Abdominal CAD, Prostate CAD, Chest CAD and Others), Application (Cancer {Breast Cancer, Lung Cancer, Colon Cancer, Prostate Cancer, Liver Cancer, Bone Cancer, & Others}, Neurological, Musculoskeletal, Cardiovascular and Others) and Region.



On the basis of geography, the market of Computer Aided Diagnosis (CAD) has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by , the sub-segment i.e. will boost the Computer Aided Diagnosis (CAD) market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Increasing Usage of Artificial Intelligence Technology in Computer-Aided Diagnosis

Market Growth Drivers:
Increase in the Patients With Medical Conditions Like Cancer and The Rise in the Geriatric Population Globally

Challenges:
Lack of Well Qualified Operators or Technicians May Pose a Challenge

Restraints:
Inadequate Reimbursement Policies May Limit the Market Penetration

Opportunities:
There is an Increased Opportunity for the Market Expansion, Owing to Surge in the Usage of CAD With Other Imaging Modalities Such as Ultrasound & Magnetic Resonance Imaging and There are Growing Prospects Due to Increasing Adoption of Computer-Aided Diagnosis by Radiologists in Urban as well as Rural Locations

Market Leaders and their expansionary development strategies
In December 2022, Olympus Corporation (Olympus) announced it has signed a definitive agreement to acquire London-based Odin Vision, a cloud-AI endoscopy company with a strong portfolio of commercially available computer-aided detection/diagnostic (CAD) solutions and a deep innovation pipeline of cloud-enabled applications, for up to GBP 66 million (approx. 11 billion JPY / 79 million USD) in upfront and milestone-based payments.
In September 2020, Olympus Corporation announced the launch of ENDO-AID, a cutting-edge platform powered by artificial intelligence (AI) and including the endoscopy application ENDO-AID CADe (computer-aided detection) for the colon. This new AI platform enables real-time display of automatically detected suspicious lesions and works in combination with the recently introduced EVIS X1, Olympus’ most advanced endoscopy system to date.


Key Target Audience
Computer-Aided Diagnosis Companies, Technology Investors, Research Institutes & Organizations, Regulatory & Government Bodies and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Breast CAD
  • Abdominal CAD
  • Prostate CAD
  • Chest CAD
  • Others
By Application
  • Cancer {Breast Cancer, Lung Cancer, Colon Cancer, Prostate Cancer, Liver Cancer, Bone Cancer, & Others}
  • Neurological
  • Musculoskeletal
  • Cardiovascular
  • Others
By Imaging Modality
  • X-Ray Imaging
  • Computed Tomography
  • Ultrasound Imaging
  • Magnetic Resonance Imaging
  • Nuclear Medicine Imaging
  • Others

By End-User
  • Hospitals
  • Diagnostic Centers
  • Research Centers
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in the Patients With Medical Conditions Like Cancer
      • 3.2.2. The Rise in the Geriatric Population Globally
    • 3.3. Market Challenges
      • 3.3.1. Lack of Well Qualified Operators or Technicians May Pose a Challenge
    • 3.4. Market Trends
      • 3.4.1. Increasing Usage of Artificial Intelligence Technology in Computer-Aided Diagnosis
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Computer Aided Diagnosis (CAD), by Type, Application, Imaging Modality, End-User and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Computer Aided Diagnosis (CAD) (Value)
      • 5.2.1. Global Computer Aided Diagnosis (CAD) by: Type (Value)
        • 5.2.1.1. Breast CAD
        • 5.2.1.2. Abdominal CAD
        • 5.2.1.3. Prostate CAD
        • 5.2.1.4. Chest CAD
        • 5.2.1.5. Others
      • 5.2.2. Global Computer Aided Diagnosis (CAD) by: Application (Value)
        • 5.2.2.1. Cancer {Breast Cancer, Lung Cancer, Colon Cancer, Prostate Cancer, Liver Cancer, Bone Cancer, & Others}
        • 5.2.2.2. Neurological
        • 5.2.2.3. Musculoskeletal
        • 5.2.2.4. Cardiovascular
        • 5.2.2.5. Others
      • 5.2.3. Global Computer Aided Diagnosis (CAD) by: Imaging Modality (Value)
        • 5.2.3.1. X-Ray Imaging
        • 5.2.3.2. Computed Tomography
        • 5.2.3.3. Ultrasound Imaging
        • 5.2.3.4. Magnetic Resonance Imaging
        • 5.2.3.5. Nuclear Medicine Imaging
        • 5.2.3.6. Others
      • 5.2.4. Global Computer Aided Diagnosis (CAD) by: End-User (Value)
        • 5.2.4.1. Hospitals
        • 5.2.4.2. Diagnostic Centers
        • 5.2.4.3. Research Centers
        • 5.2.4.4. Others
      • 5.2.5. Global Computer Aided Diagnosis (CAD) Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Computer Aided Diagnosis (CAD) (Price)
      • 5.3.1. Global Computer Aided Diagnosis (CAD) by: Type (Price)
  • 6. Computer Aided Diagnosis (CAD): Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Siemens Healthineers (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. IBM (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Hitachi High Technologies Corporation (Japan)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. GE Healthcare (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. EDDA Technology, Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Fujifilm Holdings Corporation (Japan)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Hologic Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. ICAD, Inc. (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Philips (Netherlands)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Computer Aided Diagnosis (CAD) Sale, by Type, Application, Imaging Modality, End-User and Region (value and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Computer Aided Diagnosis (CAD) (Value)
      • 7.2.1. Global Computer Aided Diagnosis (CAD) by: Type (Value)
        • 7.2.1.1. Breast CAD
        • 7.2.1.2. Abdominal CAD
        • 7.2.1.3. Prostate CAD
        • 7.2.1.4. Chest CAD
        • 7.2.1.5. Others
      • 7.2.2. Global Computer Aided Diagnosis (CAD) by: Application (Value)
        • 7.2.2.1. Cancer {Breast Cancer, Lung Cancer, Colon Cancer, Prostate Cancer, Liver Cancer, Bone Cancer, & Others}
        • 7.2.2.2. Neurological
        • 7.2.2.3. Musculoskeletal
        • 7.2.2.4. Cardiovascular
        • 7.2.2.5. Others
      • 7.2.3. Global Computer Aided Diagnosis (CAD) by: Imaging Modality (Value)
        • 7.2.3.1. X-Ray Imaging
        • 7.2.3.2. Computed Tomography
        • 7.2.3.3. Ultrasound Imaging
        • 7.2.3.4. Magnetic Resonance Imaging
        • 7.2.3.5. Nuclear Medicine Imaging
        • 7.2.3.6. Others
      • 7.2.4. Global Computer Aided Diagnosis (CAD) by: End-User (Value)
        • 7.2.4.1. Hospitals
        • 7.2.4.2. Diagnostic Centers
        • 7.2.4.3. Research Centers
        • 7.2.4.4. Others
      • 7.2.5. Global Computer Aided Diagnosis (CAD) Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Computer Aided Diagnosis (CAD) (Price)
      • 7.3.1. Global Computer Aided Diagnosis (CAD) by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Computer Aided Diagnosis (CAD): by Type(USD Million)
  • Table 2. Computer Aided Diagnosis (CAD) Breast CAD , by Region USD Million (2018-2023)
  • Table 3. Computer Aided Diagnosis (CAD) Abdominal CAD , by Region USD Million (2018-2023)
  • Table 4. Computer Aided Diagnosis (CAD) Prostate CAD , by Region USD Million (2018-2023)
  • Table 5. Computer Aided Diagnosis (CAD) Chest CAD , by Region USD Million (2018-2023)
  • Table 6. Computer Aided Diagnosis (CAD) Others , by Region USD Million (2018-2023)
  • Table 7. Computer Aided Diagnosis (CAD): by Application(USD Million)
  • Table 8. Computer Aided Diagnosis (CAD) Cancer {Breast Cancer, Lung Cancer, Colon Cancer, Prostate Cancer, Liver Cancer, Bone Cancer, & Others} , by Region USD Million (2018-2023)
  • Table 9. Computer Aided Diagnosis (CAD) Neurological , by Region USD Million (2018-2023)
  • Table 10. Computer Aided Diagnosis (CAD) Musculoskeletal , by Region USD Million (2018-2023)
  • Table 11. Computer Aided Diagnosis (CAD) Cardiovascular , by Region USD Million (2018-2023)
  • Table 12. Computer Aided Diagnosis (CAD) Others , by Region USD Million (2018-2023)
  • Table 13. Computer Aided Diagnosis (CAD): by Imaging Modality(USD Million)
  • Table 14. Computer Aided Diagnosis (CAD) X-Ray Imaging , by Region USD Million (2018-2023)
  • Table 15. Computer Aided Diagnosis (CAD) Computed Tomography , by Region USD Million (2018-2023)
  • Table 16. Computer Aided Diagnosis (CAD) Ultrasound Imaging , by Region USD Million (2018-2023)
  • Table 17. Computer Aided Diagnosis (CAD) Magnetic Resonance Imaging , by Region USD Million (2018-2023)
  • Table 18. Computer Aided Diagnosis (CAD) Nuclear Medicine Imaging , by Region USD Million (2018-2023)
  • Table 19. Computer Aided Diagnosis (CAD) Others , by Region USD Million (2018-2023)
  • Table 20. Computer Aided Diagnosis (CAD): by End-User(USD Million)
  • Table 21. Computer Aided Diagnosis (CAD) Hospitals , by Region USD Million (2018-2023)
  • Table 22. Computer Aided Diagnosis (CAD) Diagnostic Centers , by Region USD Million (2018-2023)
  • Table 23. Computer Aided Diagnosis (CAD) Research Centers , by Region USD Million (2018-2023)
  • Table 24. Computer Aided Diagnosis (CAD) Others , by Region USD Million (2018-2023)
  • Table 25. South America Computer Aided Diagnosis (CAD), by Country USD Million (2018-2023)
  • Table 26. South America Computer Aided Diagnosis (CAD), by Type USD Million (2018-2023)
  • Table 27. South America Computer Aided Diagnosis (CAD), by Application USD Million (2018-2023)
  • Table 28. South America Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2018-2023)
  • Table 29. South America Computer Aided Diagnosis (CAD), by End-User USD Million (2018-2023)
  • Table 30. Brazil Computer Aided Diagnosis (CAD), by Type USD Million (2018-2023)
  • Table 31. Brazil Computer Aided Diagnosis (CAD), by Application USD Million (2018-2023)
  • Table 32. Brazil Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2018-2023)
  • Table 33. Brazil Computer Aided Diagnosis (CAD), by End-User USD Million (2018-2023)
  • Table 34. Argentina Computer Aided Diagnosis (CAD), by Type USD Million (2018-2023)
  • Table 35. Argentina Computer Aided Diagnosis (CAD), by Application USD Million (2018-2023)
  • Table 36. Argentina Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2018-2023)
  • Table 37. Argentina Computer Aided Diagnosis (CAD), by End-User USD Million (2018-2023)
  • Table 38. Rest of South America Computer Aided Diagnosis (CAD), by Type USD Million (2018-2023)
  • Table 39. Rest of South America Computer Aided Diagnosis (CAD), by Application USD Million (2018-2023)
  • Table 40. Rest of South America Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2018-2023)
  • Table 41. Rest of South America Computer Aided Diagnosis (CAD), by End-User USD Million (2018-2023)
  • Table 42. Asia Pacific Computer Aided Diagnosis (CAD), by Country USD Million (2018-2023)
  • Table 43. Asia Pacific Computer Aided Diagnosis (CAD), by Type USD Million (2018-2023)
  • Table 44. Asia Pacific Computer Aided Diagnosis (CAD), by Application USD Million (2018-2023)
  • Table 45. Asia Pacific Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2018-2023)
  • Table 46. Asia Pacific Computer Aided Diagnosis (CAD), by End-User USD Million (2018-2023)
  • Table 47. China Computer Aided Diagnosis (CAD), by Type USD Million (2018-2023)
  • Table 48. China Computer Aided Diagnosis (CAD), by Application USD Million (2018-2023)
  • Table 49. China Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2018-2023)
  • Table 50. China Computer Aided Diagnosis (CAD), by End-User USD Million (2018-2023)
  • Table 51. Japan Computer Aided Diagnosis (CAD), by Type USD Million (2018-2023)
  • Table 52. Japan Computer Aided Diagnosis (CAD), by Application USD Million (2018-2023)
  • Table 53. Japan Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2018-2023)
  • Table 54. Japan Computer Aided Diagnosis (CAD), by End-User USD Million (2018-2023)
  • Table 55. India Computer Aided Diagnosis (CAD), by Type USD Million (2018-2023)
  • Table 56. India Computer Aided Diagnosis (CAD), by Application USD Million (2018-2023)
  • Table 57. India Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2018-2023)
  • Table 58. India Computer Aided Diagnosis (CAD), by End-User USD Million (2018-2023)
  • Table 59. South Korea Computer Aided Diagnosis (CAD), by Type USD Million (2018-2023)
  • Table 60. South Korea Computer Aided Diagnosis (CAD), by Application USD Million (2018-2023)
  • Table 61. South Korea Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2018-2023)
  • Table 62. South Korea Computer Aided Diagnosis (CAD), by End-User USD Million (2018-2023)
  • Table 63. Taiwan Computer Aided Diagnosis (CAD), by Type USD Million (2018-2023)
  • Table 64. Taiwan Computer Aided Diagnosis (CAD), by Application USD Million (2018-2023)
  • Table 65. Taiwan Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2018-2023)
  • Table 66. Taiwan Computer Aided Diagnosis (CAD), by End-User USD Million (2018-2023)
  • Table 67. Australia Computer Aided Diagnosis (CAD), by Type USD Million (2018-2023)
  • Table 68. Australia Computer Aided Diagnosis (CAD), by Application USD Million (2018-2023)
  • Table 69. Australia Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2018-2023)
  • Table 70. Australia Computer Aided Diagnosis (CAD), by End-User USD Million (2018-2023)
  • Table 71. Rest of Asia-Pacific Computer Aided Diagnosis (CAD), by Type USD Million (2018-2023)
  • Table 72. Rest of Asia-Pacific Computer Aided Diagnosis (CAD), by Application USD Million (2018-2023)
  • Table 73. Rest of Asia-Pacific Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2018-2023)
  • Table 74. Rest of Asia-Pacific Computer Aided Diagnosis (CAD), by End-User USD Million (2018-2023)
  • Table 75. Europe Computer Aided Diagnosis (CAD), by Country USD Million (2018-2023)
  • Table 76. Europe Computer Aided Diagnosis (CAD), by Type USD Million (2018-2023)
  • Table 77. Europe Computer Aided Diagnosis (CAD), by Application USD Million (2018-2023)
  • Table 78. Europe Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2018-2023)
  • Table 79. Europe Computer Aided Diagnosis (CAD), by End-User USD Million (2018-2023)
  • Table 80. Germany Computer Aided Diagnosis (CAD), by Type USD Million (2018-2023)
  • Table 81. Germany Computer Aided Diagnosis (CAD), by Application USD Million (2018-2023)
  • Table 82. Germany Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2018-2023)
  • Table 83. Germany Computer Aided Diagnosis (CAD), by End-User USD Million (2018-2023)
  • Table 84. France Computer Aided Diagnosis (CAD), by Type USD Million (2018-2023)
  • Table 85. France Computer Aided Diagnosis (CAD), by Application USD Million (2018-2023)
  • Table 86. France Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2018-2023)
  • Table 87. France Computer Aided Diagnosis (CAD), by End-User USD Million (2018-2023)
  • Table 88. Italy Computer Aided Diagnosis (CAD), by Type USD Million (2018-2023)
  • Table 89. Italy Computer Aided Diagnosis (CAD), by Application USD Million (2018-2023)
  • Table 90. Italy Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2018-2023)
  • Table 91. Italy Computer Aided Diagnosis (CAD), by End-User USD Million (2018-2023)
  • Table 92. United Kingdom Computer Aided Diagnosis (CAD), by Type USD Million (2018-2023)
  • Table 93. United Kingdom Computer Aided Diagnosis (CAD), by Application USD Million (2018-2023)
  • Table 94. United Kingdom Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2018-2023)
  • Table 95. United Kingdom Computer Aided Diagnosis (CAD), by End-User USD Million (2018-2023)
  • Table 96. Netherlands Computer Aided Diagnosis (CAD), by Type USD Million (2018-2023)
  • Table 97. Netherlands Computer Aided Diagnosis (CAD), by Application USD Million (2018-2023)
  • Table 98. Netherlands Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2018-2023)
  • Table 99. Netherlands Computer Aided Diagnosis (CAD), by End-User USD Million (2018-2023)
  • Table 100. Rest of Europe Computer Aided Diagnosis (CAD), by Type USD Million (2018-2023)
  • Table 101. Rest of Europe Computer Aided Diagnosis (CAD), by Application USD Million (2018-2023)
  • Table 102. Rest of Europe Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2018-2023)
  • Table 103. Rest of Europe Computer Aided Diagnosis (CAD), by End-User USD Million (2018-2023)
  • Table 104. MEA Computer Aided Diagnosis (CAD), by Country USD Million (2018-2023)
  • Table 105. MEA Computer Aided Diagnosis (CAD), by Type USD Million (2018-2023)
  • Table 106. MEA Computer Aided Diagnosis (CAD), by Application USD Million (2018-2023)
  • Table 107. MEA Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2018-2023)
  • Table 108. MEA Computer Aided Diagnosis (CAD), by End-User USD Million (2018-2023)
  • Table 109. Middle East Computer Aided Diagnosis (CAD), by Type USD Million (2018-2023)
  • Table 110. Middle East Computer Aided Diagnosis (CAD), by Application USD Million (2018-2023)
  • Table 111. Middle East Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2018-2023)
  • Table 112. Middle East Computer Aided Diagnosis (CAD), by End-User USD Million (2018-2023)
  • Table 113. Africa Computer Aided Diagnosis (CAD), by Type USD Million (2018-2023)
  • Table 114. Africa Computer Aided Diagnosis (CAD), by Application USD Million (2018-2023)
  • Table 115. Africa Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2018-2023)
  • Table 116. Africa Computer Aided Diagnosis (CAD), by End-User USD Million (2018-2023)
  • Table 117. North America Computer Aided Diagnosis (CAD), by Country USD Million (2018-2023)
  • Table 118. North America Computer Aided Diagnosis (CAD), by Type USD Million (2018-2023)
  • Table 119. North America Computer Aided Diagnosis (CAD), by Application USD Million (2018-2023)
  • Table 120. North America Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2018-2023)
  • Table 121. North America Computer Aided Diagnosis (CAD), by End-User USD Million (2018-2023)
  • Table 122. United States Computer Aided Diagnosis (CAD), by Type USD Million (2018-2023)
  • Table 123. United States Computer Aided Diagnosis (CAD), by Application USD Million (2018-2023)
  • Table 124. United States Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2018-2023)
  • Table 125. United States Computer Aided Diagnosis (CAD), by End-User USD Million (2018-2023)
  • Table 126. Canada Computer Aided Diagnosis (CAD), by Type USD Million (2018-2023)
  • Table 127. Canada Computer Aided Diagnosis (CAD), by Application USD Million (2018-2023)
  • Table 128. Canada Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2018-2023)
  • Table 129. Canada Computer Aided Diagnosis (CAD), by End-User USD Million (2018-2023)
  • Table 130. Mexico Computer Aided Diagnosis (CAD), by Type USD Million (2018-2023)
  • Table 131. Mexico Computer Aided Diagnosis (CAD), by Application USD Million (2018-2023)
  • Table 132. Mexico Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2018-2023)
  • Table 133. Mexico Computer Aided Diagnosis (CAD), by End-User USD Million (2018-2023)
  • Table 134. Computer Aided Diagnosis (CAD): by Type(USD/Units)
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Computer Aided Diagnosis (CAD): by Type(USD Million)
  • Table 145. Computer Aided Diagnosis (CAD) Breast CAD , by Region USD Million (2025-2030)
  • Table 146. Computer Aided Diagnosis (CAD) Abdominal CAD , by Region USD Million (2025-2030)
  • Table 147. Computer Aided Diagnosis (CAD) Prostate CAD , by Region USD Million (2025-2030)
  • Table 148. Computer Aided Diagnosis (CAD) Chest CAD , by Region USD Million (2025-2030)
  • Table 149. Computer Aided Diagnosis (CAD) Others , by Region USD Million (2025-2030)
  • Table 150. Computer Aided Diagnosis (CAD): by Application(USD Million)
  • Table 151. Computer Aided Diagnosis (CAD) Cancer {Breast Cancer, Lung Cancer, Colon Cancer, Prostate Cancer, Liver Cancer, Bone Cancer, & Others} , by Region USD Million (2025-2030)
  • Table 152. Computer Aided Diagnosis (CAD) Neurological , by Region USD Million (2025-2030)
  • Table 153. Computer Aided Diagnosis (CAD) Musculoskeletal , by Region USD Million (2025-2030)
  • Table 154. Computer Aided Diagnosis (CAD) Cardiovascular , by Region USD Million (2025-2030)
  • Table 155. Computer Aided Diagnosis (CAD) Others , by Region USD Million (2025-2030)
  • Table 156. Computer Aided Diagnosis (CAD): by Imaging Modality(USD Million)
  • Table 157. Computer Aided Diagnosis (CAD) X-Ray Imaging , by Region USD Million (2025-2030)
  • Table 158. Computer Aided Diagnosis (CAD) Computed Tomography , by Region USD Million (2025-2030)
  • Table 159. Computer Aided Diagnosis (CAD) Ultrasound Imaging , by Region USD Million (2025-2030)
  • Table 160. Computer Aided Diagnosis (CAD) Magnetic Resonance Imaging , by Region USD Million (2025-2030)
  • Table 161. Computer Aided Diagnosis (CAD) Nuclear Medicine Imaging , by Region USD Million (2025-2030)
  • Table 162. Computer Aided Diagnosis (CAD) Others , by Region USD Million (2025-2030)
  • Table 163. Computer Aided Diagnosis (CAD): by End-User(USD Million)
  • Table 164. Computer Aided Diagnosis (CAD) Hospitals , by Region USD Million (2025-2030)
  • Table 165. Computer Aided Diagnosis (CAD) Diagnostic Centers , by Region USD Million (2025-2030)
  • Table 166. Computer Aided Diagnosis (CAD) Research Centers , by Region USD Million (2025-2030)
  • Table 167. Computer Aided Diagnosis (CAD) Others , by Region USD Million (2025-2030)
  • Table 168. South America Computer Aided Diagnosis (CAD), by Country USD Million (2025-2030)
  • Table 169. South America Computer Aided Diagnosis (CAD), by Type USD Million (2025-2030)
  • Table 170. South America Computer Aided Diagnosis (CAD), by Application USD Million (2025-2030)
  • Table 171. South America Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2025-2030)
  • Table 172. South America Computer Aided Diagnosis (CAD), by End-User USD Million (2025-2030)
  • Table 173. Brazil Computer Aided Diagnosis (CAD), by Type USD Million (2025-2030)
  • Table 174. Brazil Computer Aided Diagnosis (CAD), by Application USD Million (2025-2030)
  • Table 175. Brazil Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2025-2030)
  • Table 176. Brazil Computer Aided Diagnosis (CAD), by End-User USD Million (2025-2030)
  • Table 177. Argentina Computer Aided Diagnosis (CAD), by Type USD Million (2025-2030)
  • Table 178. Argentina Computer Aided Diagnosis (CAD), by Application USD Million (2025-2030)
  • Table 179. Argentina Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2025-2030)
  • Table 180. Argentina Computer Aided Diagnosis (CAD), by End-User USD Million (2025-2030)
  • Table 181. Rest of South America Computer Aided Diagnosis (CAD), by Type USD Million (2025-2030)
  • Table 182. Rest of South America Computer Aided Diagnosis (CAD), by Application USD Million (2025-2030)
  • Table 183. Rest of South America Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2025-2030)
  • Table 184. Rest of South America Computer Aided Diagnosis (CAD), by End-User USD Million (2025-2030)
  • Table 185. Asia Pacific Computer Aided Diagnosis (CAD), by Country USD Million (2025-2030)
  • Table 186. Asia Pacific Computer Aided Diagnosis (CAD), by Type USD Million (2025-2030)
  • Table 187. Asia Pacific Computer Aided Diagnosis (CAD), by Application USD Million (2025-2030)
  • Table 188. Asia Pacific Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2025-2030)
  • Table 189. Asia Pacific Computer Aided Diagnosis (CAD), by End-User USD Million (2025-2030)
  • Table 190. China Computer Aided Diagnosis (CAD), by Type USD Million (2025-2030)
  • Table 191. China Computer Aided Diagnosis (CAD), by Application USD Million (2025-2030)
  • Table 192. China Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2025-2030)
  • Table 193. China Computer Aided Diagnosis (CAD), by End-User USD Million (2025-2030)
  • Table 194. Japan Computer Aided Diagnosis (CAD), by Type USD Million (2025-2030)
  • Table 195. Japan Computer Aided Diagnosis (CAD), by Application USD Million (2025-2030)
  • Table 196. Japan Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2025-2030)
  • Table 197. Japan Computer Aided Diagnosis (CAD), by End-User USD Million (2025-2030)
  • Table 198. India Computer Aided Diagnosis (CAD), by Type USD Million (2025-2030)
  • Table 199. India Computer Aided Diagnosis (CAD), by Application USD Million (2025-2030)
  • Table 200. India Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2025-2030)
  • Table 201. India Computer Aided Diagnosis (CAD), by End-User USD Million (2025-2030)
  • Table 202. South Korea Computer Aided Diagnosis (CAD), by Type USD Million (2025-2030)
  • Table 203. South Korea Computer Aided Diagnosis (CAD), by Application USD Million (2025-2030)
  • Table 204. South Korea Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2025-2030)
  • Table 205. South Korea Computer Aided Diagnosis (CAD), by End-User USD Million (2025-2030)
  • Table 206. Taiwan Computer Aided Diagnosis (CAD), by Type USD Million (2025-2030)
  • Table 207. Taiwan Computer Aided Diagnosis (CAD), by Application USD Million (2025-2030)
  • Table 208. Taiwan Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2025-2030)
  • Table 209. Taiwan Computer Aided Diagnosis (CAD), by End-User USD Million (2025-2030)
  • Table 210. Australia Computer Aided Diagnosis (CAD), by Type USD Million (2025-2030)
  • Table 211. Australia Computer Aided Diagnosis (CAD), by Application USD Million (2025-2030)
  • Table 212. Australia Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2025-2030)
  • Table 213. Australia Computer Aided Diagnosis (CAD), by End-User USD Million (2025-2030)
  • Table 214. Rest of Asia-Pacific Computer Aided Diagnosis (CAD), by Type USD Million (2025-2030)
  • Table 215. Rest of Asia-Pacific Computer Aided Diagnosis (CAD), by Application USD Million (2025-2030)
  • Table 216. Rest of Asia-Pacific Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2025-2030)
  • Table 217. Rest of Asia-Pacific Computer Aided Diagnosis (CAD), by End-User USD Million (2025-2030)
  • Table 218. Europe Computer Aided Diagnosis (CAD), by Country USD Million (2025-2030)
  • Table 219. Europe Computer Aided Diagnosis (CAD), by Type USD Million (2025-2030)
  • Table 220. Europe Computer Aided Diagnosis (CAD), by Application USD Million (2025-2030)
  • Table 221. Europe Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2025-2030)
  • Table 222. Europe Computer Aided Diagnosis (CAD), by End-User USD Million (2025-2030)
  • Table 223. Germany Computer Aided Diagnosis (CAD), by Type USD Million (2025-2030)
  • Table 224. Germany Computer Aided Diagnosis (CAD), by Application USD Million (2025-2030)
  • Table 225. Germany Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2025-2030)
  • Table 226. Germany Computer Aided Diagnosis (CAD), by End-User USD Million (2025-2030)
  • Table 227. France Computer Aided Diagnosis (CAD), by Type USD Million (2025-2030)
  • Table 228. France Computer Aided Diagnosis (CAD), by Application USD Million (2025-2030)
  • Table 229. France Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2025-2030)
  • Table 230. France Computer Aided Diagnosis (CAD), by End-User USD Million (2025-2030)
  • Table 231. Italy Computer Aided Diagnosis (CAD), by Type USD Million (2025-2030)
  • Table 232. Italy Computer Aided Diagnosis (CAD), by Application USD Million (2025-2030)
  • Table 233. Italy Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2025-2030)
  • Table 234. Italy Computer Aided Diagnosis (CAD), by End-User USD Million (2025-2030)
  • Table 235. United Kingdom Computer Aided Diagnosis (CAD), by Type USD Million (2025-2030)
  • Table 236. United Kingdom Computer Aided Diagnosis (CAD), by Application USD Million (2025-2030)
  • Table 237. United Kingdom Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2025-2030)
  • Table 238. United Kingdom Computer Aided Diagnosis (CAD), by End-User USD Million (2025-2030)
  • Table 239. Netherlands Computer Aided Diagnosis (CAD), by Type USD Million (2025-2030)
  • Table 240. Netherlands Computer Aided Diagnosis (CAD), by Application USD Million (2025-2030)
  • Table 241. Netherlands Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2025-2030)
  • Table 242. Netherlands Computer Aided Diagnosis (CAD), by End-User USD Million (2025-2030)
  • Table 243. Rest of Europe Computer Aided Diagnosis (CAD), by Type USD Million (2025-2030)
  • Table 244. Rest of Europe Computer Aided Diagnosis (CAD), by Application USD Million (2025-2030)
  • Table 245. Rest of Europe Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2025-2030)
  • Table 246. Rest of Europe Computer Aided Diagnosis (CAD), by End-User USD Million (2025-2030)
  • Table 247. MEA Computer Aided Diagnosis (CAD), by Country USD Million (2025-2030)
  • Table 248. MEA Computer Aided Diagnosis (CAD), by Type USD Million (2025-2030)
  • Table 249. MEA Computer Aided Diagnosis (CAD), by Application USD Million (2025-2030)
  • Table 250. MEA Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2025-2030)
  • Table 251. MEA Computer Aided Diagnosis (CAD), by End-User USD Million (2025-2030)
  • Table 252. Middle East Computer Aided Diagnosis (CAD), by Type USD Million (2025-2030)
  • Table 253. Middle East Computer Aided Diagnosis (CAD), by Application USD Million (2025-2030)
  • Table 254. Middle East Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2025-2030)
  • Table 255. Middle East Computer Aided Diagnosis (CAD), by End-User USD Million (2025-2030)
  • Table 256. Africa Computer Aided Diagnosis (CAD), by Type USD Million (2025-2030)
  • Table 257. Africa Computer Aided Diagnosis (CAD), by Application USD Million (2025-2030)
  • Table 258. Africa Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2025-2030)
  • Table 259. Africa Computer Aided Diagnosis (CAD), by End-User USD Million (2025-2030)
  • Table 260. North America Computer Aided Diagnosis (CAD), by Country USD Million (2025-2030)
  • Table 261. North America Computer Aided Diagnosis (CAD), by Type USD Million (2025-2030)
  • Table 262. North America Computer Aided Diagnosis (CAD), by Application USD Million (2025-2030)
  • Table 263. North America Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2025-2030)
  • Table 264. North America Computer Aided Diagnosis (CAD), by End-User USD Million (2025-2030)
  • Table 265. United States Computer Aided Diagnosis (CAD), by Type USD Million (2025-2030)
  • Table 266. United States Computer Aided Diagnosis (CAD), by Application USD Million (2025-2030)
  • Table 267. United States Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2025-2030)
  • Table 268. United States Computer Aided Diagnosis (CAD), by End-User USD Million (2025-2030)
  • Table 269. Canada Computer Aided Diagnosis (CAD), by Type USD Million (2025-2030)
  • Table 270. Canada Computer Aided Diagnosis (CAD), by Application USD Million (2025-2030)
  • Table 271. Canada Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2025-2030)
  • Table 272. Canada Computer Aided Diagnosis (CAD), by End-User USD Million (2025-2030)
  • Table 273. Mexico Computer Aided Diagnosis (CAD), by Type USD Million (2025-2030)
  • Table 274. Mexico Computer Aided Diagnosis (CAD), by Application USD Million (2025-2030)
  • Table 275. Mexico Computer Aided Diagnosis (CAD), by Imaging Modality USD Million (2025-2030)
  • Table 276. Mexico Computer Aided Diagnosis (CAD), by End-User USD Million (2025-2030)
  • Table 277. Computer Aided Diagnosis (CAD): by Type(USD/Units)
  • Table 278. Research Programs/Design for This Report
  • Table 279. Key Data Information from Secondary Sources
  • Table 280. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Computer Aided Diagnosis (CAD): by Type USD Million (2018-2023)
  • Figure 5. Global Computer Aided Diagnosis (CAD): by Application USD Million (2018-2023)
  • Figure 6. Global Computer Aided Diagnosis (CAD): by Imaging Modality USD Million (2018-2023)
  • Figure 7. Global Computer Aided Diagnosis (CAD): by End-User USD Million (2018-2023)
  • Figure 8. South America Computer Aided Diagnosis (CAD) Share (%), by Country
  • Figure 9. Asia Pacific Computer Aided Diagnosis (CAD) Share (%), by Country
  • Figure 10. Europe Computer Aided Diagnosis (CAD) Share (%), by Country
  • Figure 11. MEA Computer Aided Diagnosis (CAD) Share (%), by Country
  • Figure 12. North America Computer Aided Diagnosis (CAD) Share (%), by Country
  • Figure 13. Global Computer Aided Diagnosis (CAD): by Type USD/Units (2018-2023)
  • Figure 14. Global Computer Aided Diagnosis (CAD) share by Players 2023 (%)
  • Figure 15. Global Computer Aided Diagnosis (CAD) share by Players (Top 3) 2023(%)
  • Figure 16. Global Computer Aided Diagnosis (CAD) share by Players (Top 5) 2023(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Siemens Healthineers (Germany) Revenue, Net Income and Gross profit
  • Figure 19. Siemens Healthineers (Germany) Revenue: by Geography 2023
  • Figure 20. IBM (United States) Revenue, Net Income and Gross profit
  • Figure 21. IBM (United States) Revenue: by Geography 2023
  • Figure 22. Hitachi High Technologies Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 23. Hitachi High Technologies Corporation (Japan) Revenue: by Geography 2023
  • Figure 24. GE Healthcare (United States) Revenue, Net Income and Gross profit
  • Figure 25. GE Healthcare (United States) Revenue: by Geography 2023
  • Figure 26. EDDA Technology, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. EDDA Technology, Inc. (United States) Revenue: by Geography 2023
  • Figure 28. Fujifilm Holdings Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 29. Fujifilm Holdings Corporation (Japan) Revenue: by Geography 2023
  • Figure 30. Hologic Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 31. Hologic Inc. (United States) Revenue: by Geography 2023
  • Figure 32. ICAD, Inc. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 33. ICAD, Inc. (United Kingdom) Revenue: by Geography 2023
  • Figure 34. Philips (Netherlands) Revenue, Net Income and Gross profit
  • Figure 35. Philips (Netherlands) Revenue: by Geography 2023
  • Figure 36. Global Computer Aided Diagnosis (CAD): by Type USD Million (2025-2030)
  • Figure 37. Global Computer Aided Diagnosis (CAD): by Application USD Million (2025-2030)
  • Figure 38. Global Computer Aided Diagnosis (CAD): by Imaging Modality USD Million (2025-2030)
  • Figure 39. Global Computer Aided Diagnosis (CAD): by End-User USD Million (2025-2030)
  • Figure 40. South America Computer Aided Diagnosis (CAD) Share (%), by Country
  • Figure 41. Asia Pacific Computer Aided Diagnosis (CAD) Share (%), by Country
  • Figure 42. Europe Computer Aided Diagnosis (CAD) Share (%), by Country
  • Figure 43. MEA Computer Aided Diagnosis (CAD) Share (%), by Country
  • Figure 44. North America Computer Aided Diagnosis (CAD) Share (%), by Country
  • Figure 45. Global Computer Aided Diagnosis (CAD): by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Siemens Healthineers (Germany)
  • IBM (United States)
  • Hitachi High Technologies Corporation (Japan)
  • GE Healthcare (United States)
  • EDDA Technology, Inc. (United States)
  • Fujifilm Holdings Corporation (Japan)
  • Hologic Inc. (United States)
  • iCAD, Inc. (United Kingdom)
  • Philips (Netherlands)
Additional players considered in the study are as follows:
Median Technologies (France) , Carestream Health (United States) , ESAOTE SpA (Italy) , Riverain Technologies (United States) , Others
Select User Access Type

Key Highlights of Report


Apr 2024 222 Pages 77 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Computer Aided Diagnosis (CAD) Market Quantitative research analysis
Global Computer Aided Diagnosis (CAD) Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Siemens Healthineers (Germany), IBM (United States), Hitachi High Technologies Corporation (Japan), GE Healthcare (United States), EDDA Technology, Inc. (United States), Fujifilm Holdings Corporation (Japan), Hologic Inc. (United States), iCAD, Inc. (United Kingdom) and Philips (Netherlands) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increasing Usage of Artificial Intelligence Technology in Computer-Aided Diagnosis" is seen as one of major influencing trends for Computer Aided Diagnosis (CAD) Market during projected period 2023-2030.
The Computer Aided Diagnosis (CAD) market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Computer Aided Diagnosis (CAD) Market Report?

Have a Query? Click Here

Other Related Reports

AI in Drug Discovery Comprehensive Study by Application (Immuno-oncology, Neurodegenerative Diseases, Cardiovascular Diseases, Metabolic Diseases, Others), Technology (Machine Learning, Deep Learning...
$ 3650
Dosimetry Technology Comprehensive Study by Type (Active Dosimeter, Passive Dosimeter), Application (Patient Monitoring, Occupational Radiation Monitoring, Area Radiation Monitoring, Others), Solutio...
$ 3750
Consumer Genomics Comprehensive Study by Application (Genetic Relatedness, Diagnostics, Wellness and Nutrition, Ancestry, Reproductive Health, Others), Technology (Polymerase Chain Reaction (PCR), Se...
$ 3750
Workplace Stress Management Comprehensive Study by Delivery Mode (Personal Fitness Advisors, Meditation Specialists, Individual Counselors, Others), Service (Meditation & Yoga, Stress Assessment, Pro...
$ 3750
Interoperability Solutions In Healthcare Comprehensive Study by Type (Software Solutions, Services), Application (Diagnosis, Treatment, Others), Interoperability Level (Foundational Interoperability,...
$ 4200
Biobanking For Medicine Comprehensive Study by Application (Regenerative Medicine, Life Science Research, Clinical Research), Product and Service (Equipment, Consumables, Services, Software), Sample ...
$ 3750